Advisor Group Holdings, Inc. Ampio Pharmaceuticals, Inc. Transaction History

Advisor Group Holdings, Inc.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$0.08 - $21.0 $848 - $222,705	10,605 Added 7.82%	146,305 $9,000
Q2 2022 Aug 10, 2022	BUY	$0.16 - $0.47 $3,712 - $10,904	23,200 Added 20.62%	135,700 $23,000
Q1 2022 May 04, 2022	SELL	$0.42 - $0.62 $4,704 - $6,944	-11,200 Reduced 9.05%	112,500 $53,000
Q3 2021 Nov 05, 2021	BUY	$1.21 - $1.8 $7,865 - $11,700	6,500 Added 5.55%	123,700 $205,000
Q2 2021 Aug 02, 2021	SELL	$1.56 - $1.98 $12,481 - $15,841	-8,001 Reduced 6.39%	117,200 $196,000
Q1 2021 May 13, 2021	BUY	$1.36 - $2.49 $544 - $996	400 Added 0.32%	125,201 $212,000
Q4 2020 Feb 10, 2021	BUY	$0.75 - $2.76 $54,975 - $202,307	73,300 Added 142.33%	124,801 $198,000
Q3 2020 Nov 12, 2020	BUY	$0.61 - $1.17 $15,189 - $29,133	24,900 Added 93.61%	51,501 $49,000
Q2 2020 Aug 14, 2020	SELL	$0.47 - $0.72 $35,955 - $55,080	-76,500 Reduced 74.2%	26,601 $17,000
Q1 2020 May 18, 2020	BUY	$0.36 - $0.74 $37,116 - $76,294	103,101 New	103,101 $42,000

96.6K

Ticker AMPE
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 226,287,008
Market Cap $2.26M
Description
Ampio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of immunomodulatory therapies for the treatment of pain from osteoarthritis in the United States. Its product pipeline includes AP-013, an intra-articular injection, which is in phase III clinical trial for the treatment of osteoarthritis of the knee; AP-017, an...

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Advisor Group Holdings, Inc. with notifications on news.